biomarkers & Genomics
I believe healthcare technology can connect people, improve care and deliver better patient outcomes.
challenge the status quo
I see opportunites where others see roadblocks. Let's work together.
COMMITTED TO IMPROVING HEALTHCARE VALUE
Liz Cramer is an oncology molecular diagnostics sales and marketing leader passionate about improving oncology healthcare delivery through the integration of genetic and genomic technologies. Liz excels at bringing internal and external stakeholders together to work towards shared goals and inspiring her teammates to achieve their greatest potential. Every day Liz's goal is to connect people, improve care and deliver better patient outcomes.
Currently, Liz leads a diagnostic oncology sales team of Clinical Oncology Specialists as a Regional Director at Natera Oncology. Natera's novel assay, Signatera, is the first and only patient-specific, custom-built circulating tumor DNA (ctDNA) monitoring assay available for clinical use. Signatera detects the presence or absence of circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer.
Previously as Regional Business Director, at Caris Life Sciences Liz led a team covering oncology practices and major NCI designated cancer centers within four states. Caris offers a comprehensive genomic profiling service for advanced cancer patients inclusive of Next-Generation DNA Sequencing, RNA Whole Transcriptome Sequencing, Proteomics, immunotherapy diagnostics and clinical trial matching.
An experienced go-to-market sales leader, Liz has launched 10+ oncology molecular diagnostics, oncology companion diagnostics, cancer genetic tests, medical devices and pharmaceuticals within sixteen years.
While at Myriad Genetic Laboratories, Liz challenged a 15 year old notion, spearheading an initiative that opened access to cancer genetic testing for over 8,000 underserved patients in Maryland.
Outside of industry, Liz served as an Executive member of the Founding Board of Directors of Breast Care for Washington (BCW). Ms. Cramer lead BCW's launch marketing strategy, developing BCW's online presence, to take the organization from a grassroots initiative to serving patients within two years. BCW's mission is to provide breast cancer screening and diagnostics to all women, regardless of ability to pay.
As part of the Rare Genomics Institute Scientific team, Liz served as a diagnostics life cycle marketing product manager, working with a team of PhD's to develop pre-launch strategy for rareREACH, an online database used to match patients with rare diseases with researchers, in hopes of a diagnosis and treatment.
Liz has a special interest in leveraging social media in healthcare. In 2012, Liz founded PUGTATO, a blog that focuses on trends in healthcare marketing and social media strategy. PUGTATO has been featured by patient communities, LinkedIn pulse channels and healthcare advertising agencies.
Liz holds an M.B.A. from the University of Maryland, and a B.A. in Economics from Bucknell University.
Naturally persuasive and articulate in presentation, I am an idea generator. Building a brand's identity, developing marketing messaging and compassionately understanding the needs of patients and providers in ways that improve healthcare value all energize me.